Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study

Official Title

Maternal And Neonatal Outcome of Pregnant Patients With COVID-19

Brief Summary

Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers

Status

Completed

Conditions

COVID19

Maternal-Fetal Relations

Interventions

Other: newborns from covid 19 positive mothers

Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers

Eligibility Criteria

Inclusion Criteria:

- from covid 19 positive mothers

- newborn mothers had not other condition or illness

Exclusion Criteria:

- from covid 19 negative mothers

- childs

Eligibility Gender

All

Eligibility Age

Minimum: 1 Minute ~ Maximum: 15 Minutes

Countries

Turkey

Locations

Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey

NCT Number

NCT04337320

MeSH Terms

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Seda Yilmaz Semerci

Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA